DUBLIN, December 08, 2021–(BUSINESS WIRE)–The "Global Healthcare Cyber Security" report has been added to ResearchAndMarkets.com's offering.
The Global Healthcare Cyber Security Market size is expected to reach $28.4 billion by 2027, rising at a market growth of 16.3% CAGR during the forecast period.
Key Market Players
Cisco Systems, Inc.
FireEye, Inc.
IBM Corporation
Kaspersky Lab
Lockheed Martin Corporation
Fortified Health Security
Palo Alto Networks, Inc.
Sensato
Symantec Corporation (Broadcom, Inc.)
Cyber security technologies and solutions are constantly getting advanced because of the ever-changing threat landscape, where threats are becoming more sophisticated and damaging. In the present connected health environment, cyber security has become a necessity for healthcare organizations as it is a crucial strategic asset that is being deployed by all companies.
In the last couple of years, the healthcare sector has deployed a healthcare information technology (healthcare IT) infrastructure to access, forward, and receive electronic health data. As medical records have a big volume of data that can be utilized for identity theft and fraud (like social security numbers, claims data, or addresses), personal health information has a superior value on the black market as compared to other industries.
The growth of healthcare cyber security is expected to witness bright prospects due to the surge in the number of cyberattacks in the healthcare sector, increase in the number of threats, and growing concerns regarding privacy and security. The growing cases of data breaches and cyberattacks around the world have increased the concerns, hence boosting the demand for cyber security solutions in the global market. For example, the Secretary of U.S. Department of Health and Human Services (HHS) Breach of Unsecured Protected Health Information reported 592 breaches of unsecured protected health data impacting above 500 individuals in the past two years that are presently being investigated by the Office for Civil Rights.
COVID-19 Impact Analysis
The outbreak of the COVID-19 pandemic fueled the deployment of cyber security services and solutions due to the rise in the number of threats of data breaches and increase cases of cyberattacks in the healthcare system. The demand for cyber security solutions is expected to be driven by the increasing phishing cases in the healthcare industry during the global pandemic.
The requirement and adoption of cyber security are anticipated to be boosted by the rise in penetration of the internet and the adoption of digital platforms by the healthcare sector. Moreover, the high adoption rate of advanced cyber security solutions is expected to contribute to the growth & demand of healthcare cyber security solutions during the forecasting period. In addition, the rise in investments in healthcare cyber security by several healthcare companies and government initiatives is expected to create new growth avenues for the overall healthcare cyber security market during the forecasting period.
Market Growth Factors:
The growing number of government regulations and rising adoption of mobile device applications and platforms
High requirement for a robust authentication mechanism
Market Restraining Factor:
Absence of trained professionals
Key Topics Covered:
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis – Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansions – Healthcare Cyber Security Market
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions : 2017, Jun – 2021, Jun) Leading Players
Chapter 4. Global Healthcare Cyber Security Market by Threat Type
4.1 Global Malware Market by Region
4.2 Global DDoS Market by Region
4.3 Global Advanced Persistent Threat Market by Region
4.4 Global Spyware Market by Region
4.5 Global Lost or Stolen Devices Market by Region
4.6 Global Other Threat Type Market by Region
Chapter 5. Global Healthcare Cyber Security Market by End Use
5.1 Global Hospitals Market by Region
5.2 Global Health Insurance Market by Region
5.3 Global Pharma & Chemicals Market by Region
5.4 Global Medical Devices Market by Region
5.5 Global Other End uses Market by Region
Chapter 6. Global Healthcare Cyber Security Market by Solution
6.1 Global Antivirus and Antimalware Healthcare Cyber Security Market by Region
6.2 Global Intrusion Detection System/ Intrusion Prevention System Healthcare Cyber Security Market by Region
6.3 Global Security Information and Event Management Healthcare Cyber Security Market by Region
6.4 Global Identity and Access Management Healthcare Cyber Security Market by Region
6.5 Global Risk and Compliance Management Healthcare Cyber Security Market by Region
6.6 Global DDoS Mitigation Healthcare Cyber Security Market by Region
6.7 Global Others Healthcare Cyber Security Market by Region
Chapter 7. Global Healthcare Cyber Security Market by Region
Chapter 8. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/vu2zac
View source version on businesswire.com: https://www.businesswire.com/news/home/20211208005743/en/
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Novavax (NASDAQ: NVAX), one of the more up-and-down coronavirus stocks, headed south at the end of the week. There was no significant news about Novavax's high-profile NVX-CoV2373 coronavirus vaccine, at least on the developmental or regulatory front. Rather, between Thursday night and Friday morning a pair of law firms issued reminders that their class action lawsuits against the company were moving forward. One of those suits, filed by San Francisco-based firm Hagens Berman, alleges that the "Defendants misrepresented Novavax's progress toward successfully developing its COVID-19 vaccine."
The shares could be the first to cross that boundary. Virtual-reality headsets could send them further into the unknown.
If these companies' growth prospects were good enough before the omicron-fueled rout, they're even better now.
Most investors likely know three things about Sea Limited (NYSE: SE): that it owns Shopee, the top e-commerce player in Southeast Asia and Taiwan; that it owns the mobile game publisher Garena; and that it is deeply unprofitable. Four years ago, Garena launched Free Fire, its first self-developed mobile game.
Shares of fintech powerhouse Square (NYSE: SQ) had dipped 3% as of noon ET on Friday, despite receiving a generally positive endorsement from investment bank Jefferies today. In a note covered on TheFly.com today, Jefferies argues that Square stock is a buy and deserves a target of $240 per share, because all the bad news from Square's November earnings report is now baked into the price, and the stock looks "catalyst-rich in 2022." The bad news: Jefferies thinks that monthly active users of Square's Cash App are growing more slowly than previously expected, and points to "commentary from management" indicating a downside in the growth rate in the fourth quarter of 2021.
In this article, we discuss the 10 new stocks Reddit’s WallStreetBets is buying. If you want to skip our detailed analysis of these stocks, go directly to 5 New Stocks Reddit’s WallStreetBets is Buying. Internet platform Reddit became perhaps the single most disruptive force at the stock market this year as retail investors use the […]
(Bloomberg) — Strong building demand and renewed supply challenges have sent lumber prices surging to the highest in six months. Most Read from BloombergAnatomy of a Bad RoadThe 15 Best Beers We Drank This YearSand and Soldiers Mix as Troops Move In to Protect Cancun TouristsThe World’s Relentless Demand for Chips Turns Deadly in MalaysiaFormer Oil Trader Is Now Betting on Lumber for SkyscrapersLumber futures on the Chicago Mercantile Exchange jumped 4.4% to a six-month high of $1,069.30 per 1,
For his second "Executive Decision" segment of Thursday's Mad Money program, Jim Cramer spoke with Jim Farley, CEO of Ford Motor , about the company's turnaround. Farley said Ford has momentum and is in a great cash position, which has allowed it to reward shareholders by reinstating its dividend. Farley said Ford is oversubscribed on all of its EVs and it has stopped taking new reservations for the F-150 Lightning pickup truck.
It was not immediately clear if Musk, a prolific user of the social media platform, was being serious about quitting his roles. Musk, who is also the founder and CEO of rocket company SpaceX, and leads brain-chip startup Neuralink and infrastructure firm The Boring Company, said during a conference call in January that he expects to be the CEO of Tesla for "several years." Musk was fined $20 million by the U.S. Securities and Exchange Commission for tweets in 2018 and was required to step down as chairman.
We at Insider Monkey have gone over 867 13F filings that hedge funds and prominent investors are required to file by the SEC. The 13F filings show the funds’ and investors’ portfolio positions as of September 30th. In this article, we look at what those funds think of Energy Transfer L.P. (NYSE:ET) based on that […]
A legendary name has just bought a whole lot more of Ford's stock.
As of 10:15 a.m. ET, Figs shares had declined by 16% to the lowest level since it went public in May. CFO Jeffrey Lawrence announced his intention to retire, effective Dec. 24. Lawrence came out of retirement in December 2020 to lead Figs' financial house through its initial public offering (IPO).
The Dow Jones Industrial Average is an index made up of 30 of the largest and most influential companies on U.S. stock exchanges. Not every stock in the Dow Jones has performed well. Biotech company Amgen (NASDAQ: AMGN) has been down about 7% since the beginning of 2021.
Even in the midst of a bullish market trend, some stocks are going to fall. That’s just a fact of the markets, and the risk in stock investing. But – just because a stock falls, doesn’t mean investors should avoid it. In fact, a falling price can be a strong signal for investors start checking it out more closely, to find out if the stock is fundamentally unsound or simply facing a transient headwind. One source investors can turn to for that signal is the world of corporate insiders. These are
The market is experiencing a major loss of confidence in software maker Everbridge (NASDAQ: EVBG), the self-proclaimed "global leader in critical event management." One analyst bit the bullet and went all the way to underperform on Everbridge: Bank of America's Brad Sills. On Thursday night, Everbridge abruptly announced that CEO David Meredith had told the board of directors that he intended to resign, and the board had accepted his resignation.
Peloton shares get hammered again due to a surprising plot twist in the new Sex and the City
Extending their 6% slide down yesterday, shares of fuel cell specialist Plug Power (NASDAQ: PLUG) are continuing to plunge today. Plug Power announced after the market closed yesterday that it had completed the acquisition of Frames Group — a deal that had been announced in early November. According to Plug Power, Frames Group "designs, builds, and delivers processing equipment, separation technologies, flow control and safeguarding systems, for water and renewable energy solutions."
MarketWatch Picks has highlighted these products and services because we think readers will find them useful; the MarketWatch News staff is not involved in creating this content. MarketWatch’s Jeffrey Bartash reported this week. For investors, that news was, no doubt, worrisome, so we looked at what two financial bigwigs, Suze Orman and Ramit Sethi, as well as other pros, have told investors in the past about dealing with inflation (psst: both say you need to keep investing in stocks.) Here (and below) are Bankrate’s list of featured investing products for December.
Passive income from these overweight heavyweights can help you sleep soundly at night.
A decade ago, smartphones and electric cars were barely a thing. Now, if you bought Apple or Tesla (NASDAQ: TSLA) stock a decade ago, it's worked out very well for you. Crowdstrike Holdings (NASDAQ: CRWD) uses its proprietary "Falcon" platform to link all its customers together on a cloud-based network.

source